Therapeutic Asset Ratings
396 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ly4170156
Triple-Negative Breast Carcinoma
Eli Lilly and Company
P1
CC
(43)
ly4257496
Esophageal Cancer
Eli Lilly and Company
P1
CC
(43)
ly4257496
Prostate Neoplasm
Eli Lilly and Company
P1
CC
(43)
ly4337713
Esophageal Cancer
Eli Lilly and Company
P1
CC
(43)
ly4584180
Diffuse Large B-Cell Lymphoma
Eli Lilly and Company
P1
CC
(43)
ly4584180
Non-Hodgkin Lymphoma
Eli Lilly and Company
P1
CC
(43)
Pembrolizumab
SMARCA4-Deficient Sarcoma Of Thorax
Eli Lilly and Company
P1
CC
(43)
Cetuximab
Ovarian Neoplasm
Eli Lilly and Company
P1/2
CC
(43)
Olomorasib
Colorectal Neoplasm
Eli Lilly and Company
P1/2
CC
(43)
Olomorasib
Ovarian Neoplasm
Eli Lilly and Company
P1/2
CC
(43)
LODAPOLIMAB
Neoplasm
Eli Lilly and Company
P1
CC
(42)
Itraconazole
Endometrial Cancer
Eli Lilly and Company
P1
CC
(41)
Itraconazole
Pancreatic Neoplasm
Eli Lilly and Company
P1
CC
(41)
Itraconazole
Uterine Cervix Neoplasm
Eli Lilly and Company
P1
CC
(41)
Loxo-338
B-Cell Chronic Lymphocytic Leukemia
Eli Lilly and Company
P1
CC
(41)
Loxo-338
Waldenstrom Macroglobulinemia
Eli Lilly and Company
P1
CC
(41)
ly3295668 erbumine
Neuroblastoma
Eli Lilly and Company
P1
CC
(41)
ly3410738
Acute Myeloid Leukemia
Eli Lilly and Company
P1
CC
(41)
ly3971297
Hypertensive Disorder
Eli Lilly and Company
P1
CC
(41)
ly4064912
Obesity Disorder
Eli Lilly and Company
P1
CC
(41)
ly4152199 - iv
Diffuse Large B-Cell Lymphoma
Eli Lilly and Company
P1
CC
(41)
ly4152199 - iv
Waldenstrom Macroglobulinemia
Eli Lilly and Company
P1
CC
(41)
ly4170156
Endometrial Cancer
Eli Lilly and Company
P1
CC
(41)
ly4170156
Pancreatic Neoplasm
Eli Lilly and Company
P1
CC
(41)
ly4170156
Uterine Cervix Neoplasm
Eli Lilly and Company
P1
CC
(41)
Showing 276 to 300 of 396 assets
Previous
Page 12 of 16
Next
